Literature DB >> 2914486

The quality of well-being in cystic fibrosis.

D M Orenstein1, P A Nixon, E A Ross, R M Kaplan.   

Abstract

Traditional outcome measures in CF include PFTs, exercise tests, and several scoring systems that depend on pulmonary status and are largely subjective. The Quality of Well-being scale (QWB) is a widely used tool for measuring quality of life by three subscales: mobility, physical activity, and social activity, with points assigned within each subscale. The QWB has been shown to be valid in patients with COPD. We administered the QWB scale to 44 patients with CF, aged 7 to 36 years, and examined the relationship between QWB and PFTs, and in 15 patients the QWB vs exercise performance (peak VO2) on a progressive cycle ergometer test. QWB was significantly correlated with each variable examined: QWB vs FEV1, r = 0.5518 (p less than .0001); QWB vs FEF25-75%, r = 0.4793 (p less than .001); QWB vs PEFR, r = 0.4018 (p less than .01); QWB vs peak VO2, r = 0.5778 (p less than .01). The QWB scale is an objective measure that is significantly correlated with measures of performance and pulmonary function in CF. The relationship is not one of identity; further, the QWB is broad based and takes into account general well-being, not just pulmonary health, adding an important dimension to the care of patients with CF.

Entities:  

Mesh:

Year:  1989        PMID: 2914486     DOI: 10.1378/chest.95.2.344

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  32 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

2.  Comparison of three generic questionnaires measuring quality of life in adolescents and adults with cystic fibrosis: the 36-item short form health survey, the quality of life profile for chronic diseases, and the questions on life satisfaction.

Authors:  L Goldbeck; T G Schmitz
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

Review 3.  Exercise recommendations for individuals with cystic fibrosis.

Authors:  S R Boas
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

4.  Home IV Antibiotic Therapy and Exercise Capacity in Children with CF: A Case Series.

Authors:  Narelle S Cox; Karen O McKay; Jennifer M Follett; Jennifer A Alison
Journal:  Cardiopulm Phys Ther J       Date:  2011-03

5.  The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument.

Authors:  Kerstin Wenninger; Pierre Aussage; Ulrich Wahn; Doris Staab
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

6.  Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.

Authors:  Bernadette Henry; Pierre Aussage; Cécile Grosskopf; Jean-Marie Goehrs
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

Review 7.  Quality of life in cystic fibrosis.

Authors:  D E Tullis; G H Guyatt
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

Review 8.  Exercise and cystic fibrosis.

Authors:  A K Webb; M E Dodd; J Moorcroft
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

9.  Gender differences in habitual activity in children with cystic fibrosis.

Authors:  H C Selvadurai; C J Blimkie; P J Cooper; C M Mellis; P P Van Asperen
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

10.  Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis.

Authors:  R Suri; R Grieve; C Normand; C Metcalfe; S Thompson; C Wallis; A Bush
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.